Exhibit 107
Calculation of Filing Fee Tables
Post-Effective Amendment No. to Form F-1
(Form Type)
Addex Therapeutics Ltd.
(Exact Name of Registrant as Specified in Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||
Fees to Be Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | Equity | Shares, nominal value CHF 1 per share (1) | 457(c) | 14,709,342 | $ | 0.85 | (2) | $ | 12,502,941 | 0.0000927 | N/A | F-1 | 333-262050 | January 18, 2022 | $ | 1,418.10 | ||||||||||||||||||||||
Total Offering Amounts | 0.0000927 | $ | 1,159.02 | |||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 1,418.10 | ||||||||||||||||||||||||||||||||||||
Total Fee Offsets | $ | - | ||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | - |
(1) | These ordinary shares are represented by ADSs, each of which represents six ordinary shares of the registrant. ADSs issuable on deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-235561). |
(2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the registrant’s ADSs on the Nasdaq Capital Market on March 23, 2022, of $0.85. |